Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey

ConclusionNurses and patients in the UK and Germany preferred the Imraldi autoinjector over both the Humira and Enbrel MyClic autoinjectors, which may be a consideration, along with other factors, for treatment decisions in the management of patients with inflammatory joint or bowel disease.FundingBiogen International GmbH.

http://link.springer.com/10.1007/s40744-019-0144-8

Source: Rheumatology and Therapy - February 21, 2019 Category: Rheumatology Source Type: research